Skip to Main Content

Advertisement

Skip Nav Destination

The use of nilotinib or dasatinib after failure to 2 prior tyrosine kinase inhibitors: long-term follow-up

Blood (2009) 114 (20): 4361–4368.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement